Small-Cap REIT ETF ...
Health Care: Drugs
Alexion Pharmaceuticals Inc. (ALXN: NASDAQ)
$102.90 1.08 | 1.06%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 254.82M | 175.32M | 97.03M | 295.17M |
| Operating Gains/Losses | -2.69M | 615.00K | 76.00K | 271.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -72.87M | -78.78M | -59.24M | -36.44M |
| (Increase) Decrease in Inventories | -6.26M | -12.18M | -14.12M | 14.60M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 61.72M | 79.78M | 47.46M | 14.13M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 13.17M | 15.03M | 1.32M | 400.00K |
| Other Non-Cash Items | 84.72M | 51.68M | 38.02M | 28.90M |
| Net Cash From Continuing Operations | 410.61M | 270.08M | 160.91M | 113.84M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 410.61M | 270.08M | 160.91M | 113.84M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 94.46M | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -21.85M | -21.98M | -12.84M | -63.02M |
| Acquisitions | -605.74M | -105.89M | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | -129.86M | -19.03M |
| Other Cash from Investing Activities | -4.00K | -307.00K | -2.00K | 618.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -627.58M | -33.72M | -89.32M | -81.42M |
| Issuance of Debt | 355.00M | 60.00M | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 528.65M | 35.76M | 37.55M | 30.73M |
| Repayment of Long-Term Debt | -206.00M | -60.73M | -649.00K | -44.35M |
| Repurchase of Capital Stock | -11.55M | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 279.00K | 4.02M | 1.97M | -652.00K |
| Net Cash From Financing Activities | 666.38M | 39.05M | 38.87M | -14.27M |
| Effect of Exchange Rate Changes | -768.00K | -1.70M | -482.00K | 1.01M |
| Net Change in Cash & Cash Equivalents | 448.64M | 273.72M | 109.97M | 19.16M |
Portfolios with ALXN
- Portfolio NameUser Type
- User5 S&P 500 stocks poised for...
- ProNavellier & Associates
- UserGFNN Stockdiagnostics 27
- ContributorRocket Stocks for the Week ...
- UserRenzo's portfolio
- UserBender
- UserGFNN Stockdiagnostics 18
- Contributor10 Stocks of Top-Performing...
- UserMoney Making Machine
- UserGFNN Stockdiagnostics 17
Latest ALXN Headlines from TheStreet
- Alexion Pharmaceuticals Inc. Stock Buy Recommendation Reiterated (ALXN) 04.19.13 | 10:04 am
- Worth Repeating: Vertex Is the Next Gilead Sciences 04.19.13 | 08:04 am
- 5 Stocks Pushing The Drugs Industry Downward 04.15.13 | 01:04 pm
- Top Insider Trades: DGIT GDP ALXN SPB 04.15.13 | 08:04 am
- Alexion Pharmaceuticals Becomes #42 Most Shorted Nasdaq 100 Component, Replacing KLA-Tencor 04.10.13 | 04:04 pm
- Market Takes Aim at Historic Highs Once Again
04.10.13 | 09:04 am - Alexion Pharmaceuticals Inc. (ALXN): Today's Favorite Health Care Gainer 04.04.13 | 05:04 pm
- Mad Money Uncovered: Biomarin and Alexion Orphan Drug Stalwarts 04.02.13 | 11:04 am
- Cramer's Top Stock Picks: HES ALXN BMRN NFLX ENB AWK 04.02.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Checking My List 04.01.13 | 07:04 pm
Press Releases for ALXN
- Alexion Joins The International Federation Of Kidney Foundations In Celebrating World Kidney Day 2013 - Business Wire 03.14.13 | 06:03 am
- Alexion To Present At The Barclays Global Healthcare Conference - Business Wire 03.05.13 | 10:03 am
- Alexion Joins Eurordis, NORD And Patient Organizations Worldwide In Celebrating Rare Disease Day 2013 - Business Wire 02.28.13 | 06:02 am
- Alexion To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.25.13 | 10:02 am
- Alexion Reports Fourth Quarter And Full Year 2012 Results - Business Wire 02.14.13 | 06:02 am
- Alexion Recommends Rejection Of Mini-Tender Offer By TRC Capital Corporation - Business Wire 02.07.13 | 06:02 am
- Alexion Pharmaceuticals To Report Fourth Quarter And Full Year 2012 Results On Thursday, February 14, 2013 - Business Wire 01.31.13 | 10:01 am
- Alexion To Present At The JP Morgan 31st Annual Healthcare Conference - Business Wire 01.02.13 | 10:01 am
- New Data Highlighting Long-Term Efficacy And Safety Outcomes Of PNH Patients Treated With Soliris® Reported At ASH Annual Meeting - Business Wire 12.10.12 | 10:12 am
- Alexion To Present At The 24th Annual Piper Jaffray Healthcare Conference - Business Wire 11.21.12 | 10:11 am
Partner Headlines for ALXN
- Stocks Maintain Early Lead; Drugmakers Alexion, Regeneron Climb - Investor's Business Daily 04.02.13 | 12:04 pm
- Market Close Report: NASDAQ Composite index closes at 3,239.17 down -28.35 points - NASDAQ 04.01.13 | 08:04 pm
- Regeneron Pharmaceuticals Inc (REGN): Today's Most Compelling Buy - NASDAQ 03.14.13 | 04:03 pm
- Market Close Report: NASDAQ Composite index closes at 3,182.03 up 12.29 points - NASDAQ 03.04.13 | 09:03 pm
- Trouble At A Stock's Breakout Could Be Sell Signal - Investor's Business Daily 03.04.13 | 05:03 pm
- Following The Leaders Is Way To Reap Windfall Profits - Investor's Business Daily 02.22.13 | 04:02 pm
- Market Close Report: NASDAQ Composite index closes at 3,131.49 down -32.92 points - NASDAQ 02.21.13 | 09:02 pm
- Market Close Report: NASDAQ Composite index closes at 3,213.59 up 21.56 points - NASDAQ 02.19.13 | 09:02 pm
- Pre-Market Earnings Report for February 14, 2013 : PEP, GM, APA, ABX, DTV, CVE, PPL, ALXN, SLF, WM, REGN, ECA - NASDAQ 02.13.13 | 09:02 pm
- Raptor To Rise On Proven Strategy & Upcoming FDA Decision - Seeking Alpha 12.28.12 | 09:12 am
